There are 26 records that matched your search criteria

Date Title Category
14-Sep-2009 Caution Statement on “Potential for an Increase in Risk of Suicidal Thoughts or Behaviours” required to be included in the product package insert for Antiepileptik.
Bil (43) dlm. BPFK/PPP/01/03 dated 14th Sept 2009 		DCA letters
14-Sep-2009 Caution Statement on “Possible Interaction between Clopidogrel and Proton Pump Inhibitors” required to be included in the product package insert for Clopidogrel
Bil (42) dlm. BPFK/PPP/01/03 dated 14th Sept 2009 		DCA letters
14-Sep-2009 Caution Statement on “Potential For an increase in risk of Hepatotoxicity” required to be included in the product package insert for Propylthiouracil
Bil (41) dlm. BPFK/PPP/01/03 dated 14th Sept 2009 		DCA letters
14-Sep-2009 Caution Statement on “Potential For an increase in risk of Hepatotoxicity” required to be included in the product package insert for Propylthiouracil
Bil (41) dlm. BPFK/PPP/01/03 dated 14th Sept 2009 		DCA letters
15-Sep-2009 Advertisement on Products for nicotine replacement therapy with MAB Approval
Bil (37) dlm KKM-55/205/001/02 Jld 5 dated 15th Sept 2009 		MAB Letter
13-Oct-2009 Caution Statement on “Severe Drug Interaction Between Colchicine and P-Glycoprotein or Strong CYP3A4 Inhibitors” required to be included in the product package insert for Colchicine
Bil (44) dlm. BPFK/PPP/01/03 dated 13th October 2009 		DCA letters
13-Oct-2009 Caution Statement on “Increased Risk for Opportunistic Infections such as Activation of Latent Viral Infections Including BK Virus-Associated Nephropathy” required to be included in the product package insert for Immunosuppressant
Bil (44) dlm. BPFK/PPP/01/03 dated 13th October 2009 		DCA letters
12-Nov-2009 8th List for BE Studies for Oral “Immediate Release” Generic Products
Bil (46) dlm. BPFK/PPP/01/03 dated 30th October 2009 		DCA letters
14-Apr-2010 Rules and regulation drug control regulations and cosmetics 1984 (Amendment 2006). Instruction numbers for two years in 2010. NPCB Circular on
Bil (49) dlm. BPFK/PPP/01/03 dated 14th April 2010 		DCA letters
12-May-2010 PhAMA participated in the NKEA Workshop organized by PEMANDU.
On 12 May 2010 at the Malaysia Airlines Academy, PhAMA participated in the National Key Economic Areas (NKEA)... 		General News
25-May-2010 NPCB Circular on Quest 3 launch
Bil (49) dlm. BPFK/PPO/03/02 dated 25th May 2010 		NPCB
25-May-2010 The Full evaluation launch module of QUEST3
Bil (45) dlm. BPFK/PPO/03/02 Bhg 3 dated 25th May 2010 		DCA letters
22-Jul-2010 The statement warned: "Contraindicated In Children Under 2 Years of Age" that must be filled in the package insert of all products carbocysteine, acetylcarbocysteine and methylcarbocysteine (Mecysteine)
Bil (54) dlm. BPFK/PPP/01/03 dated 22nd Jul 2010 		DCA letters
22-Jul-2010 Caution Statement on "Boxed warning" must include Propylthiouracil with "Severe Liver Injury"
Bil (55) dlm. BPFK/PPP/01/03 dated 22nd Jul 2010 		DCA letters
16-Aug-2010 Cosmetic products that are use around the eye and packaging that are not permitted for the product.
Bil (40) dlm. BPFK/17/K/2.2 dated 16th Aug 2010 		DCA letters
14-Sep-2010 Products use on the male/female genitals for sexual purposes which is not categories as cosmetic classification
Bil (41) dlm. BPFK/17/K/2.2 dated 14th Sept 2009 		DCA letters
23-Feb-2011 PhAMA Annual Games 2011
 General News
23-Feb-2011 PhAMA 39th AGM Notice - 31 March 2011
 General News
23-Feb-2011 Briefing on 'Competition Act 2010'
by the Ms Shila Dorai Raj, Director of the Interim Competition Commission, MDTCC 		General News
23-Feb-2011 PhAMA: NKEA - Pemandu Steering committee mtg - 22nd Feb 2011 @ 10 a.m
 General News